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Overview: Babesiosis is a tick-borne protozoan
disease caused by parasites of the genus
Babesia that belong to the Piroplasmida. 
The disease is named after the Romanian
bacteriologist Victor Babeş. Babesiosis is also
known as piroplasmosis (from Latin pirum,
meaning ‘pear’, and plasma, ‘image, formation’).
Infection: Babesiosis affects domestic and 
wild animals and humans worldwide. While the
disease is recognised in dogs around the world,
it is found only rarely in cats. 
Human disease: Babesia species are common
blood parasites of mammals. Human babesiosis
is uncommon, but more cases in people have
been reported recently, most likely because of
rising awareness. 
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is
a body of experts in immunology, vaccinology and clinical
feline medicine that issues guidelines on prevention and
management of feline infectious diseases in Europe, for
the benefit of the health and welfare of cats. The
guidelines are based on current scientific knowledge of
the diseases and available vaccines concerned.
The latest version of the babesiosis in cats 
guidelines is available at www.abcd-vets.org
Agent properties
Several Babesia species have been detected in domestic cats in different
regions of the world, including South Africa, Sudan, Zimbabwe, Israel,
India, Thailand, Brazil, France, Poland and Germany. However, only
few of these Babesia organisms have been characterised. 
Most reports about babesiosis in cats come from South Africa, where
it is mainly found in coastal areas. There (as well as in other parts of
Africa, such as the Sudan) infection is caused principally by B felis, 
a small Babesia species that causes severe anaemia and icterus.1,2
Most other small Babesia species
in domestic cats, like B cati
found primarily in India, are
less pathogenic.
B leo, another small species, is
genetically similar to B felis and
common in lions of the Kruger
National Park, South Africa, and
in Swaziland,3 but also prevalent
in domestic cats in these areas. 
A small Babesia species was also
seen in blood smears of cats in
Rio de Janeiro, Brazil, but the
species was not identified.
Sporadic cases of canine Babesia species infections in domestic cats
have been reported in Europe, such as B canis canis in Spain and
Portugal, a B microti-like species in Portugal, and a B canis-like species
in Poland.2 B canis presentii has been detected in Israel, and B canis
vogeli is common in stray cats in Thailand.4–6
In addition to the small B leo, several large Babesia species, including
B herpailuri and B pantherae, have been discovered in wild felids, such
as lions, cheetahs and the Florida panther. They can be transmitted
experimentally to domestic cats, but their infectivity and pathogenici-
ty under natural circumstances is unknown.2
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Several new species (eg, B venatorum) have
been discovered in recent years. A new species,
named B hongkongensis, was discovered in 
kidney sections of a free-roaming cat in Hong
Kong.7 The level of genetic diversity within
Babesia species suggests that new subspecies
can develop easily.8
Life cycle
Babesioses are vector-borne diseases usually
transmitted by ticks. The vector(s) for Babesia
species in cats has/have not yet been 
identified. 
Babesia organisms replicate in erythrocytes,
where they produce merozoites. These struc-
tures appear as inclusions attached to each
other at their ends, thereby forming tetrads.
These so-called Maltese cross formations are
pathognomonic of Babesia species. Ticks are
infected by ingesting merozoites during feed-
ing, and replication of the parasite within
their salivary cells results in sporozoite forma-
tion. When infected ticks feed, the sporozoites
are regurgitated and fed back into the blood-
stream of the host.
Epidemiology
B felis is the most important pathogenic
species in cats. It is mainly found in the coastal
areas of South Africa.1,2 It usually occurs in
cats less than 3 years of age, without any
predilection for sex or breed.9,10
Apart from the usual transmission by ticks,
Babesia species have been transmitted iatro-
genically (eg, through blood transfusions).
Virulence is determined primarily by the 
parasite species involved.
Clinical signs
Severe disease has been described in cats
infected with B felis in South Africa, where
feline babesiosis is diagnosed regularly.1 This
species has not been reported in Europe to
date. In contrast, feline babesiosis caused by
other Babesia species presents as a chronic,
mild disease.4
Common clinical signs are anorexia, lethar-
gy, weakness and a rough haircoat.9,11 Unlike
in dogs, fever and icterus are uncommon. In
most cases with fever, a concurrent illness is
diagnosed.11 Most clinical signs are secondary
to haemolytic anaemia that results from the
infection of erythrocytes by the piroplasms.
Cats usually cope with the anaemia and may
show only mild clinical signs.
Complications of babesiosis include renal
failure, pulmonary oedema, hepatopathy and
central nervous system signs.11 Concurrent
infection with Mycoplasma hemofelis, feline
leukaemia virus (FeLV) or feline immunodefi-
ciency virus (FIV) can contribute to the clinical
presentation and severity of disease.
The typical laboratory findings in cats with
babesiosis are a consequence of haemolytic
anaemia, which is usually regenerative,
macrocytic and hypochromic. Haemolysis can
be caused by both extravascular and intra -
vascular erythrolysis.10 Anaemia is most 
pronounced approximately 3 weeks after an
experimental infection.12 Blood smears can
show increased polychromatophils, Howell-
Jolly bodies, nucleated erythrocytes and
anisocytosis.11 Erythrophagocytosis by mono-
cytes is also observed,11 and intra-erythrocytic
parasites can sometimes be detected.10
Secondary, immune-mediated haemolytic
anaemia with anti-erythrocyte antibodies can
occasionally be seen, leading to a positive
Coombs’ test and autoagglutination.10
Infected cats usually show no changes in
their white blood cells. Thrombocytopenia is
common in other species but is an inconsistent
finding in cats.10,12
On serum biochemistry, alanine transami-
nase (ALT) activity is elevated in most cases,
whereas alkaline phosphatase (ALP) activity is
generally within the reference range.1,10
Total bilirubin concentration is commonly
increased,10 most likely as a result of haemoly-
sis, but secondary hepatocellular injury can be
a contributing factor.1 Feline babesiosis usual-
ly does not alter urea, creatinine and choles-
terol concentrations, or blood pH.13 Polyclonal
gammopathy has been observed in cats with
hypergammaglobulinaemia, leading also to
increased total protein concentrations.10
Immunity
The host generates a specific immune
response against most Babesia species, but this
does not eliminate the parasite. Cats that
recover from the clinical signs usually remain
chronic carriers. 
The vector(s) for Babesia species in cats 
has/have not yet been identified.
Severe disease has been described in cats 
infected with B felis in South Africa, where feline
babesiosis is diagnosed regularly. In contrast, feline
babesiosis caused by other Babesia species
presents as a chronic, mild disease.
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Diagnosis
Babesiosis is suspected when merozoites are
detected in blood smears. Parasites are best
identified in thin smears examined at maxi-
mum magnification under oil, using
Romanowsky (methylene blue and eosin) or
Giemsa stains (Figure 1). The different Babesia
species and some other blood parasites,
including Cytauxzoon felis, are more morpho-
logically indistinguishable.2 When the level of
parasitaemia is low, which is often the case,
detection of the organism in blood smears can
be difficult. 
Testing for anti-Babesia antibodies is widely
used in dogs, but not in cats so far. 
Currently, the best method for definitive
diagnosis of Babesia species infection in cats is
detecting the organism’s nucleic acid in blood
samples by polymerase chain reaction [EBM
grade III].8 Techniques have been developed
for simultaneous detection of several Babesia
species, but differentiation between species
(eg, through nucleotide sequence differences
within the 18S ribosomal subunit) is also 
possible.2,4,8
Treatment and prognosis
The prognosis depends on the severity of dis-
ease, which in turn depends on both organism
and host factors. Mortality rates of 15–20% have
been reported [EBM grade IV].14 Concurrent
infection with M hemofelis, FeLV or FIV has a
negative impact on the response to treatment
and outcome of disease [EBM grade III].10
Antiprotozoal drugs and supportive care
are the mainstays of therapy. Cats infected
with B felis should always be treated, as the
infection is commonly fatal if left untreated. 
In a review of 20 cats with experimentally
induced babesiosis and 70 natural cases, all
untreated animals eventually died [EBM
Figure 1 Blood smear from
a cat with Babesia species
in its erythrocytes 
(inset shows a smear at
higher magnification).
Courtesy of Katrin Hartmann,
Ludwig Maximilians University,
Munich, Germany
grade III].11 The response to treatment is 
generally good, but recurrence of clinical
signs and chronic persistent infections are
possible,13 and repeated or extended treat-
ment may be necessary.1
Most antibabesial drugs are not effective in
cats and, when used in experimental studies
to treat B felis infection, have shown variable
or questionable results [EBM grade III].15,16
Currently, the drug of choice is primaquine
phosphate, an antimalarial compound. The
following dosages were found to be effective:
administration of 0.5 mg/kg PO q24h for 1–3
days, or 1 mg/cat IM q36h for four doses, then
1 mg/cat every 7 days for four doses [EBM
grade III].17 However, although primaquine
phosphate is capable of reducing para-
sitaemia, it does not eliminate B felis from the
host. Also, it frequently causes vom iting when
administered orally. Due to its narrow 
therapeutic window in cats it has to be 
administered carefully, as dosages exceeding
1 mg/kg can be lethal.15 Rifampicin and sulfa-
diazine–trimethoprim were shown to have
some antiparasitic effect in one study, but
were less active than primaquine phosphate,
while buparavaquone, enrofloxacin and dano -
floxacin did not show any antibabesial effect
[EBM grade III].16
Prevention
As Babesia species are transmitted by different
tick species, tick control is the best way to 
prevent infection [EBM grade IV]. Since cats
do not tolerate permethrin, other drugs 
(eg, fipronil) need to be used. 
The soluble parasite antigen of several
Babesia species has been used experimentally
as a vaccine against the clinical manifestations
of babesiosis, with variable success against
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< Babesiosis is a common tick-borne protozoan disease affecting
animals and humans worldwide; it is rare in cats.
< Babesiosis is caused by intracellular parasites of the genus
Babesia that belong to the Piroplasmida.
< Small and large Babesia species have been detected in domestic
cats in different regions of the world, but only a few of them have
been characterised.
< Most reports about feline babesiosis are from South Africa,
where infection is mainly caused by the small, pathogenic B felis.
< B felis can cause severe anaemia and icterus in cats; other
Babesia species are less pathogenic and rarely cause clinical
signs.
< Babesia species infection in cats is usually diagnosed when the
parasite is detected in blood smears; the best diagnostic method
is PCR.
< Treatment consists of antiprotozoal drugs and supportive
therapy; repeated or prolonged treatment might be necessary.
< The drug of choice is primaquine phosphate.
< Tick control is the best way to prevent infection.
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